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Osmotic swelling and rupture of endosomes will therefore be facilitated if the flow of K + down its concentration gradient from the cytosol into the endosome can be facilitated without allowing downhill flow of Na + from the endosome into the cytosol. While any K + selective ionophore can promote the K + specific influx, the ideal K + ionophore will also exchange influxed K + for an osmotically inactive proton (H + ) in order to prevent buildup of an electrical potential that would rapidly halt K + influx. The only ionophore that catalyzes this exchange of K + for H + efficiently
is nigericin. We demonstrate here that ligand-targeted delivery of nigericin into endosomes that contain an otherwise impermeable fluorescent dye can augment release of the dye into the cell cytosol via swelling/bursting of the entrapping endosomes. We further show that nigericinfacilitated escape of a folate-targeted luciferase siRNA conjugate from its entrapping endosomes
Introduction
Although the majority of prescription drugs today are small organic molecules, their share of the pharmaceutical market is declining in favor of biological macromolecules which now comprise ~39% of drugs in the pharmaceutical pipeline. 1 This shift towards biologics has been driven by both the diversity of biologic molecules that can be exploited for pharmacologic applications (e.g. oligonucleotides, 2 genes, 3 proteins, 4,5 peptides, 6 carbohydrates, 7,8 immune conjugates, [9] [10] [11] synthetic biopolymers, 12 etc.) and the increased numbers of diseases for which biologic therapies seem well suited. [13] [14] [15] [16] [17] Unfortunately, a major constraint still limiting the use of biologics is their inability to cross membranes, thereby confining their sites of action largely to extracellular spaces. Thus, the predominant targets of biologics today still constitute cell surface antigens, 18 secreted cytokines, 18 transmembrane receptors, 19 cell adhesion molecules, 20 and extracellular matrix proteins; 21, 22 i.e., leaving the desirable intracellular signaling complexes, transcription factors, enzymatic pathways, structural assemblies, coding and noncoding RNAs, and chromatin remodeling components largely unaddressed. 23 Although membrane barriers that restrict most biologics to extracellular spaces may differ somewhat among classes of macromolecular drugs, the most commonly encountered barrier lies in crossing the endosomal membrane. Thus, with the aid of a receptor-binding ligand, most macromolecules can be delivered via receptor-mediated endocytosis into an intracellular compartment. However, escape from that intracellular compartment into the cytoplasm is usually a low probability event. For example, during pinocytosis extracellular solutes can become entrapped within tiny (100 nm diameter) membrane invaginations that pinch off and traffic through intracellular endosomes, however, the internalized macromolecules rarely escape their entrapping compartments at any site along this pathway. 24 Similarly, during macropinocytosis much larger quantities of extracellular medium can become engulfed by a different internalization mechanism, 25 28 For example, cationic lipids and peptides are not only often toxic, but they may also bind nonspecifically to cell surfaces, thereby compromising potential applications in targeted drug delivery. 29 While "proton sponges" can induce counterion uptake and the consequent osmotic swelling of entrapping endosomes, they are also frequently toxic and the amount of material required to promote endosome lysis can also be clinically impractical. 30 And although pore-forming peptides can mediate escape of small molecules from intracellular compartments, their small pore sizes almost invariably prevent their use for delivery of larger biologics. 28 Finally, despite the established ability of certain photoactivatable dyes to induce endosomal lysis, use of such photolytic agents requires illumination of the targeted cell with a light source, greatly restricting its applicability to tissues that can be irradiated with light. [31] [32] [33] Taken together, an efficient method for facilitating release of biologics from entrapping endosomes is still lacking, and any new approach that might improve biologic delivery justifies further scrutiny. The strategy below has the potential to achieve this objective. 
Summary of Strategy
In theory, any mechanism that can enhance the unidirectional entry of an osmotic solute into an endosome must promote the osmotic swelling of that endosome. In considering possible strategies that might induce this unidirectional flux of ions into an endosome, we realized that the endocytic process actually establishes the osmotic conditions that can facilitate such influx. Thus, any mammalian plasma membrane that invaginates and pinches off inside a cell will entrap a Na + rich extracellular fluid within the endosome and exclude a K + rich intracellular fluid that comprises the cytosol (Fig. 1); i.e. setting up both K + and Na + gradients across the endosomal membrane. 34, 35 Thus, any ionophore that can selectively 
Results
To conduct an initial test of the concept proposed in Fig. 1 , we first investigated whether nigericin 1 ( Fig. 2A) 40 that is rapidly cleaved upon disulfide reduction, thereby releasing free nigericin into the entrapping endosome. As seen in Fig. 2B , escape of the membrane-impermeable dye, calcein, from the synthetic unilamellar liposomes was maximal when the vesicles were quantitatively lysed with detergent (Triton X-100) (positive control). In contrast, release of the impermeable calcein was minimal when only buffer plus DMSO were added (negative control).
Importantly, when the vesicle suspension was exposed to either free nigericin 1 or folatenigericin conjugate (ester 2, 100 nM) in the presence of 20 mM dithiothreitol (to promote disulfide bond reduction and nigericin release), nearly maximal escape of calcein was again observed (Fig. 2B ). Evidence that this calcein release was dependent on a Na + /K + gradient across the liposomal membrane was established by demonstrating a lack of calcein release when the intraliposomal Na + was exchanged for the same concentration of liposomal K + (i.e. the electrochemical gradient was collapsed). Taken together, these data demonstrate that nigericin can mediate the bursting of a membrane-encapsulating compartment if the compartment is constructed with a Na + /K + transmembrane gradient similar to that seen in endosomes. To determine whether nigericin might promote similar bursting of intracellular endosomes in living cells, we next treated FR-positive KB cells with a folate-rhodamine conjugate 4 (Fig. 3A) that readily enters FR-expressing cells via folate receptor-mediated endocytosis. 39 Although the folate-rhodamine conjugate was designed to release free rhodamine following its endocytosis (due to reduction of its disulfide bond in intracellular endosomes) 39 , the discharged rhodamine is known to remain entrapped within the endosome due to its strong positive and negative charges. 41 To evaluate whether nigericin might enable release of this entrapped rhodamine, 10 nM folate-rhodamine was added to FR-positive KB cells, both in the presence and absence of 100 nM folate-nigericin ester 2. Because many FR are known to internalize into the same FRpositive endosome, 42 it was anticipated that multiple copies of both conjugates 2 and 4 would be internalized into each endosome, allowing the released nigericin to catalyze the escape of the rhodamine entrapped within the same endosome.
As shown in Fig. 3B , the aforementioned predictions were only partially realized. As anticipated, within 1 h of conjugate 2 addition, rhodamine containing endosomes were seen to swell only in those cells treated with both folate-rhodamine plus folate-nigericin 2, but not in cells treated solely with folate-rhodamine. These data suggested that folate-nigericin 2 was indeed required for endosome swelling. By 2 h post-administration, however, many of the nigericin-containing endosomes had continued to enlarge, expanding eventually to many times the size of folate-rhodamine containing endosomes in cells not treated with folate-nigericin, but surprisingly without bursting. Indeed, only a fraction of the swollen endosomes displayed plumes of escaping free rhodamine emerging from their surfaces (see green arrow, Fig. 3B ).
Although by 3 h post-administration a greater fraction of the swollen endosomes showed plumes of released rhodamine (along with diffuse rhodamine staining within the cytoplasm), the majority of rhodamine fluorescence appeared to remain encapsulated within the greatly enlarged endosomes. Because endosomes in cells treated solely with folate-rhodamine 4 remained relatively unchanged except for the slow migration of the fluorescent endosomes towards the cell's interior, we conclude that enlargement and periodic rupture of endosomes requires the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 involvement of folate-nigericin. Whether the unanticipated continual endosome expansion occurs because the initial endosomes are part of an elaborate anastomosing network of intracellular compartments that share a common encapsulating membrane, or because the swelling endosomes are induced to rapidly fuse to increase their surface to volume ratios cannot be ascertained from the data. However, the fact that some release of contents occurs during swelling motivated us to explore this endosome escape strategy further. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57 To determine whether nigericin-mediated endosome swelling might be exploited to deliver a larger folate-targeted biologic into a cell's cytosol, we next constructed the folate-siRNA conjugate 5 shown in Fig. 4A , where the targeting ligand (folate) was conjugated to the 3' end of one strand of a duplex siRNA, while a fluorescent dye (Dylight 647; (Dy647)) was linked to the 3' end of the complementary strand ( However, by 5 h post-administration, significant swelling, aggregation and pluming of fluorescence can be seen from endosomes in the folate-nigericin 2 treated samples, but not in control cells. Although these data suggest that endosome swelling and leakage may require more time to release the larger folate-siRNA conjugate, the end result appears to be the same, with endosome swelling and release of Dy647-siRNA (see green arrows in Fig. 4B ) also occurring when the biologic is larger. (Fig. 5A, conjugate 6 ) might prove equally potent in promoting endosome swelling. As shown in Fig. 5B , endosome swelling and release was equally effective with the carbamate conjugate 6 as with the ester conjugate 2 (100 nM). Thus, not only was significant endosome enlargement/aggregation also apparent, but the usual plumes of released dye could even be seen inside the cells as early as 1 h after exposure (Fig. 5B) . These data suggest that use of the more stable carbamate linker does not compromise nigericin's ability to promote endosome bursting. To further minimize any possible nigericin-mediated toxicity, we next explored whether lower concentrations of folate-nigericin might induce similar endosome swelling and rupture. As shown in Fig.6A , 60 nM folate-nigericin carbamate conjugate 6 still promoted endosome enlargement and rhodamine release(see Fig. 5B ). Curiously, 30 nM folate-nigericin carbamate conjugate 6 was also effective at inducing endosome enlargement and rhodamine release (Fig.   6B ). In contrast, still lower concentrations of folate-nigericin showed increasingly weaker potency (data not shown), suggesting that concentrations of targeted nigericin below 30 nM might not be adequate for catalysis of endosome swelling and rupture. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 again only observed in cells treated with a folate-nigericin conjugate, with pluming of rhodamine fluorescence appearing more frequently in cultures treated with the folate-nigericin amide than its ester counterpart. In fact, except for a somewhat delayed progression of the swelling/bursting process in MDA-MB-231 cells, the response of the cells to co-delivery of nigericin was similar to that seen in KB cells.
Next, to explore whether a still more unrelated cell type might display a similar response to cointernalization of nigericin, we again conducted identical studies on RAW 264.7 cells, a malignant macrophage cell line that differs from KB cells not only in its cell of origin, but also in its targeted receptor (i.e. RAW264.7 cells express the beta form of the folate receptor rather than the alpha isoform present on KB and MDA-MB-231 cells). 44 As displayed in Fig. 7B , codelivery of nigericin into RAW264.7 endosomes promoted both endosome swelling and rhodamine release in a similar but less prominent manner than seen in KB cells. And again, these perturbations were completely absent in cells not treated with folate-nigericin. Finally, to confirm that the apparent nigericin-mediated swelling and leakage of endosomal contents can deliver a functional biologic into a target cell, the ability of a folate-conjugated antisense oligonucleotide (siLuc2) to suppress luciferase 2 gene expression was examined. For this purpose, MDA-MB-231 cells were stably transfected to constitutively express luciferase 2 and then incubated with a folate-siLuc2 antisense conjugate either lacking (structure 7) or containing at attached nigericin (structure 8). As shown in Fig. 8C , no difference in luciferase activity could be detected between the two constructs for the first 18 h of incubation (perhaps due to the large number of pre-existing copies of luciferase enzyme in the cells). However, at later time points a significant difference in luciferase activity was observed, with little reduction seen in cultures exposed to the folate-siRNA lacking nigericin, but a significant decrease seen in cultures treated with the conjugate containing nigericin (see Fig. S14 in Supporting Information for more controls). The reduced potency of luciferase gene suppression by the construct lacking nigericin strongly argues that endosome swelling and leakage can be facilitated by co-delivery of nigericin into the endosomes. Why might a nigericin-mediated endosome lysis strategy be preferred over other endosome release mechanisms? From our perspective, use of nigericin may primarily be favored because of its ease of translation into the clinic. Thus, nigericin is a small, stable, well-characterized, nontoxic, and easily conjugatable organic molecule that can be attached via a variety of selfimmolative linkers to virtually any biologic molecule destined for clinical use. Because the resulting conjugate can be prepared in a homogeneous formulation that can be molecularly characterized by FDA-approved methods, 54 its stability and manufacturing reproducibility should be readily documentable. Moreover, by avoiding problems with toxicity, homogeneity and efficacy that can plague cell permeating peptides, polycations, pore-forming peptides, and proton sponges, many of the pitfalls that limit utility of other endosome escape mechanisms can be circumvented. It is our hope that with further refinement and optimization, incorporation of one 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 or more nigericins (or a related ionophore) into biologic drugs will eventually enable their use in the treatment of diseases that are driven by intracellular targets. Liposomes were refrigerated (0-4 °C) until use.
Materials and Methods

Preparation of Calcein
Characterization of the liposomes:
The liposome size and zeta-potential were measured using dynamic light scattering (Zetasizer Nano ZS, Malvern). Measurements were performed by dispersing liposomes in buffer (1:500) (130 mM KCl/20 mM K 3 PO 4 buffer, pH 7.6). The temperature was set at 25 °C for all measurements. Three measurements were made per sample, and the averaged data was reported. The size of the liposomes were in the range of 400 ± 15 nm and charge of the liposome were -49.0 ± 1.6 mV
Cryo-TEM measurement:
The liposomes were applied to lacey carbon grids (Ultrathin Carbon
Film on a Lacey Carbon Support Film, 01824, Ted Pella) in 3 uL volume under ~90% relative humidity and double-blotted for 6 seconds. The liposome sample was flash frozen in liquid ethane using the semi-automated plunger Cp3 (Gatan). The flash-frozen sample was loaded on a CM200 transmission electron microscope under liquid nitrogen cryogenic conditions. The sample was screened at a nominal magnification of 50,000 X for the presence of liposomes.
Micrographs were binned twice using ImageJ to better visualize liposomes (see Supporting   Information, Fig. S15 ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Determination of Nigericin Toxicity (IC 50 )
. KB cells (100,000 cells/well) were seeded on amine-coated 24-well plates and allowed to form monolayers. After allowing the cells to reach ~60% confluence, spent medium was replaced with fresh medium and the desired concentrations of nigericin were added to each well. After incubating for 2 h at 37 °C, cells were rinsed 3× with fresh medium and then incubated an additional 66 h at 37 °C in fresh medium. Spent medium in each well was again replaced with fresh medium (0.5 mL) containing 3 H-thymidine (1 µCi/ml), and the cells were incubated for an additional 4 h. After washing the cells 3× with medium, they were dissolved in 0.5 mL of 0.25 M NaOH. Thymidine incorporation was then determined by counting cell-associated radioactivity using a scintillation counter (Packard, Packard Instrument After replacement of the medium, different concentrations of the following reagents were then added to the wells: vehicle (DMSO), tubulysin, nigericin, and folate-nigericin. The plates were then placed in an IncuCyte S3 imaging instrument (Essen Bioscience), and each well was imaged every four hours for 24 hours using standard mode scan with a 10X objective and a red filter.
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